ATE89288T1 - L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. - Google Patents

L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE89288T1
ATE89288T1 AT89103699T AT89103699T ATE89288T1 AT E89288 T1 ATE89288 T1 AT E89288T1 AT 89103699 T AT89103699 T AT 89103699T AT 89103699 T AT89103699 T AT 89103699T AT E89288 T1 ATE89288 T1 AT E89288T1
Authority
AT
Austria
Prior art keywords
pyroglutamyl
activity
anticataractogenic
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT89103699T
Other languages
English (en)
Inventor
Giuseppe Dr Benanti
Victor Prof Rizza
Original Assignee
S I F I Societa Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I F I Societa Ind Farmaceuti filed Critical S I F I Societa Ind Farmaceuti
Application granted granted Critical
Publication of ATE89288T1 publication Critical patent/ATE89288T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT89103699T 1988-03-15 1989-03-03 L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. ATE89288T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8819783A IT1216096B (it) 1988-03-15 1988-03-15 L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
EP89103699A EP0332946B1 (de) 1988-03-15 1989-03-03 L-Pyroglutamyl-L-cystein-Dipeptid mit hoher anti-cataractogener Wirkung und dies enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE89288T1 true ATE89288T1 (de) 1993-05-15

Family

ID=11161182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89103699T ATE89288T1 (de) 1988-03-15 1989-03-03 L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.

Country Status (5)

Country Link
EP (1) EP0332946B1 (de)
AT (1) ATE89288T1 (de)
DE (1) DE68906437T2 (de)
ES (1) ES2053834T3 (de)
IT (1) IT1216096B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
IT1256178B (it) * 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5624955A (en) * 1995-05-03 1997-04-29 Regents Of The University Of Minnesota Compounds that enhance the concentration of glutathione in tissues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500847A (nl) * 1984-03-29 1985-10-16 Sandoz Ag Gesubstitueerde alfa-aminozuren, hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
EP0332946B1 (de) 1993-05-12
DE68906437D1 (de) 1993-06-17
IT8819783A0 (it) 1988-03-15
ES2053834T3 (es) 1994-08-01
EP0332946A1 (de) 1989-09-20
DE68906437T2 (de) 1993-09-09
IT1216096B (it) 1990-02-22

Similar Documents

Publication Publication Date Title
DE3686483D1 (de) Arzneimittel.
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
EP0473084A3 (en) Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides
ATE182786T1 (de) Pharmazeutische und/oder kosmetische zubereitung
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
DE69010139D1 (de) Haarkräftigungsmittel.
DK0553890T3 (da) Diphenylheteroalkylderivater, deres fremstilling og lægemidler og kosmetisk fremstillet derudfra
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE121295T1 (de) Augentropfenarzneimittel.
DE69006654D1 (de) Einen Zink-Komplex enthaltende Arzneimittel.
SE8404065D0 (sv) Novel biologically active compounds
IT1228288B (it) Composti ad attivita' antiserotoninica
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE89288T1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
DK0487613T3 (da) Megakarycytopiesk faktor
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
DE69111530D1 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
NZ231087A (en) Piperidino-ethoxy benzoyl benzoate derivatives and pharmaceutical compositions
ES2162992T3 (es) Uso de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento.
IT8847610A0 (it) Composizioni farmaceutiche adattivita' antiprolattinica
ITRM910829A1 (it) Derivati dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee